Qian Yuan Baixing, Inc.
QYBX
Other OTC0.01
USD
- -
- -
CIK
0001376668
ISIN
US74737T1016
CUSIP
74737T101
Return %
Stock
S&P500
1Y
-5.54
18.99
3Y
105.59
64.75
5Y
-85.38
71.84
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Zhi Cao
- Full Time Employees
- 15
- Sector
- Technology
- Industry
- Consumer Electronics
- Address
- 601 Union Street Seattle WA United States of America 98101
- IPO Date
- Apr 8, 2008
- CIK
- 0001376668
- Similar Companies
- Business
- Qian Yuan Baixing, Inc. Qian Yuan Baixing, Inc. (QYBX) operates as a holding company focused on e-commerce, health supplements, and biotechnology sectors; it sells goods and services through internet platforms and produces, processes, and distributes soft capsules for nutritional supplements along with related technical consulting services. The company conducts its principal operations in China through wholly owned subsidiaries, including Panjin Chunqiu Century Industrial Co., Ltd. (Chunqiu), acquired in July 2021 for assets valued at $98,000 via issuance of 2,000,000 restricted common shares, which handles social networking, e-commerce, and an online shopping mall targeting small stores and consumer demand in up to 100 cities; and Hangzhou Mai Jin Li Biotechnology Co., Ltd. (Mai Jin Li), fully acquired in March 2023 for 3,000,000 unregistered common shares valued at $9,600, specializing in high-end health foods leveraging upstream industrial chains and traditional Chinese medicine formulations for rehabilitation and wellness products with minimal side effects. Qian Yuan Baixing integrates Chunqiu's online and offline sales channels with Mai Jin Li's production capabilities to form a complementary supply chain, emphasizing product quality improvements, scientific collaborations with pharmaceutical firms, development of proprietary varieties, and expansion into international markets; it serves national and potentially global customers seeking high-quality, tech-enhanced health and consumer goods. Founded in 2005 as Bridgefilms Inc. in Nevada and formerly known as MDCorp., General Automotive Co., Utility Investment Recovery Inc., and others, with a name change to Qian Yuan Baixing, Inc. in April 2018, the company maintains its headquarters at 601 Union Street Suite 4200, Seattle, Washington 98101, and reports recent financial performance including $1,057,158 in quarterly revenue and $80,505 net income for the three months ended March 31, 2024, driven by customer advances and operational growth from the Mai Jin Li acquisition which contributed a $722,461 gain in 2023. No additional major partnerships, funding rounds, new product launches, or strategic shifts beyond the 2021 and 2023 acquisitions appear in recent disclosures as of mid-2024.